Composition:
Pantoprazole Sodium IP equivalent to Pantoprazole 40 mg + Domperidone IP 30 mg (as sustained-release pellets)
PANLI DSR is a dual-action capsule containing Pantoprazole 40 mg and Domperidone 30 mg in sustained-release form. It combines acid suppression with improved gastric motility and is indicated for the management of GERD, acid peptic disorders, dyspepsia, nausea, vomiting and associated gastrointestinal symptoms.
Dual-action acid control and gastric motility support
Pantoprazole 40 mg for sustained acid suppression
Domperidone 30 mg as sustained-release pellets
Helps improve gastric emptying and intestinal motility
Convenient once-daily dosage
Effective and sustained acid suppression
Helps improve gastric emptying and intestinal motility
Helps control nausea, vomiting and bloating
Better symptom control in GERD and dyspepsia
Convenient once-daily dosage
Composition: Pantoprazole Sodium IP equivalent to Pantoprazole 40 mg + Domperidone IP 30 mg
